Variation in Medicaid and commercial coverage of cell and gene therapies
Growth in the availability of cell and gene therapies (CGTs) promises significant innovation in the treatment of serious diseases, but the high cost and one-time administration of CGTs has also raised concern about strain on health plan budgets and inequity in access. We used coverage information fr...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2023-12-01
|
| Seri Bilgileri: | Health Policy Open |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2590229623000151 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|